{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:29:59Z","timestamp":1792416599465,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ijantimicag.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T09:32:24Z","timestamp":1277890344000},"page":"295-302","source":"Crossref","is-referenced-by-count":39,"title":["Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future"],"prefix":"10.1016","volume":"36","author":[{"given":"K.","family":"Mazumdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Asok Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/48.4.463","article-title":"The problem with cephalosporins","volume":"48","author":"Dancer","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1078\/1438-4221-00185","article-title":"Resistance mechanisms of Gram-positive bacteria","volume":"292","author":"Berger-B\u00e4chi","year":"2002","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/14750708.1.1.1","article-title":"Wildcatters welcome: the need for new antimicrobial agents","volume":"1","author":"Ray","year":"2004","journal-title":"Therapy"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.01033-06","article-title":"Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei","volume":"51","author":"Chan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dkm071","article-title":"Reversal of resistance in microorganisms by help of non-antibiotics","volume":"59","author":"Kristiansen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138945006777709584","article-title":"The reversal of drug resistance from bacteria to cancer cells","volume":"7","author":"Molnar","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib8","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.49.8.3578-3582.2005","article-title":"Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes","volume":"49","author":"Viveiros","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","article-title":"Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus","volume":"47","author":"Kaatz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib10","first-page":"135","article-title":"Antimicrobial activity of non-antibiotics","volume":"57","author":"Kristiansen","year":"1991","journal-title":"ASM News"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/40.3.319","article-title":"The potential management of resistant infections with non-antibiotics","volume":"40","author":"Kristiansen","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/AAC.35.9.1923","article-title":"Effects of chlorpromazine on the cell envelope proteins of Escherichiacoli","volume":"35","author":"Amaral","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines","volume":"17","author":"Viveiros","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2007.04.018","article-title":"Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jac\/dkl500","article-title":"Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps","volume":"59","author":"Amaral","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187152108783329807","article-title":"Enhanced killing of intracellular pathogenic bacteria by phenothiazines and the role of K+ efflux pumps of the bacterium and the killing macrophage","volume":"7","author":"Amaral","year":"2008","journal-title":"Anti Infect Agents Med Chem"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","article-title":"Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities","volume":"31","author":"Martins","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10096-009-0739-z","article-title":"The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target","volume":"28","author":"Mazumdar","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/35.6.721","article-title":"The Garrod Lecture. Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs","volume":"35","author":"Williams","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib20","first-page":"285","article-title":"Amlodipine: a cardiovascular drug with powerful antimicrobial property","volume":"52","author":"Kumar","year":"2003","journal-title":"Acta Microbiol Pol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0255-0857(21)03067-X","article-title":"Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochloride","volume":"21","author":"Sarkar","year":"2003","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib22","first-page":"847","article-title":"Studies on the antimicrobial potential of the cardiovascular drug lacidipine","volume":"21","author":"Dasgupta","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib23","first-page":"539","article-title":"In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-l-DOPA","volume":"19","author":"Dutta","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3742\/OPEM.2006.6.2.126","article-title":"Assessment of antibacterial activity of the cardiovascular drug nifedipine","volume":"6","author":"Pal","year":"2006","journal-title":"Oriental Pharm Exp Med"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1078\/0944-5013-00204","article-title":"Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride","volume":"158","author":"Mazumdar","year":"2003","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10096-007-0439-5","article-title":"In vitro efficacy of diclofenac against Listeria monocytogenes","volume":"27","author":"Dutta","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1472-765X.2008.02391.x","article-title":"The anti-inflammatory drug diclofenac retains anti-listerial activity in vivo","volume":"47","author":"Dutta","year":"2008","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijantimicag.2009.09.027","article-title":"Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74","volume":"35","author":"Dasgupta","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"e10069","DOI":"10.1371\/journal.pone.0010069","article-title":"A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine","volume":"5","author":"Dutta","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2009.12.019","article-title":"Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!","volume":"35","author":"Amaral","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1076\/ocii.6.1.13.8083","article-title":"A clinical evaluation of diclofenac\u2013gentamicin combination eye drops in the control of inflammation after cataract surgery. Diclofenac\u2013Gentamicin versus Gentamicin Study Group","volume":"6","author":"Shepherd","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pmed.0040344","article-title":"Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model","volume":"4","author":"Rosenthal","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib33","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1099\/jmm.0.014027-0","article-title":"Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacteriumtuberculosis in mice","volume":"58","author":"Dutta","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0924-8579(00)00131-X","article-title":"Interaction between antibiotics and non-conventional antibiotics on bacteria","volume":"14","author":"Gunics","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02549770","article-title":"Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis","volume":"22","author":"Moln\u00e1r","year":"1990","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jac\/30.4.556","article-title":"Synergic effect of chlorpromazine on the activity of some antibiotics","volume":"30","author":"Amaral","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","article-title":"Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib39","first-page":"5814","article-title":"Antimicrobial effects of anesthetics and analgesics","volume":"161","author":"Bender","year":"1999","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.52.4.490","article-title":"Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents","volume":"52","author":"Wang","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib41","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1248\/bpb.27.1116","article-title":"Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine","volume":"27","author":"Asok Kumar","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10096-009-0845-y","article-title":"Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine","volume":"29","author":"Dasgupta","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1248\/bpb.28.713","article-title":"In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains","volume":"28","author":"Mazumdar","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.micres.2004.10.002","article-title":"Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine","volume":"160","author":"Rani Basu","year":"2005","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S1466252308001527","article-title":"Novel approaches to discovery of antibacterial agents","volume":"9","author":"Taylor","year":"2008","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2008.102","article-title":"Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities","volume":"61","author":"Fukumoto","year":"2008","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib47","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/AAC.01071-07","article-title":"Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonasaeruginosa","volume":"52","author":"Khalil","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2672.2008.03820.x","article-title":"Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant Gram-negative bacterial pathogens","volume":"105","author":"Saha","year":"2008","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib49","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1128\/JB.00510-09","article-title":"The Mycobacterium tuberculosis sigma factor \u03c3B is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth","volume":"191","author":"Font\u00e1n","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib50","first-page":"94","article-title":"The diclofenac stimulon of Staphylococcus aureus","volume":"A-065\/001","author":"Dupre","year":"2009","journal-title":"ASM"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib51","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.bmc.2007.01.030","article-title":"Antituberculosis drugs: ten years of research","volume":"15","author":"Janin","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib52","first-page":"783","article-title":"In vitro synergistic effect of gentamicin with the anti-inflammatory agent diclofenac against Listeria monocytogenes","volume":"48","author":"Dutta","year":"2009","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10096-009-0703-y","article-title":"In vitro and in vivo efficacies of amlodipine against Listeria monocytogenes","volume":"7","author":"Dutta","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2006.01.007","article-title":"A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia","volume":"112","author":"Li","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib55","first-page":"2413","article-title":"Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse","volume":"52","author":"Taylor","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/AAC.00522-07","article-title":"Oral therapy with amlodipine and lacidipine, 1,4-dihydropyridine derivatives showing activity against experimental visceral leishmaniasis","volume":"52","author":"Palit","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2007.10.003","article-title":"Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography\u2013mass spectrometry","volume":"33","author":"Suchanova","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib58","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0091270006291097","article-title":"Effect of food on the bioavailability of amlodipine besylate\/atorvastatin calcium combination tablet","volume":"46","author":"Chung","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1742-7843.2007.00055.x","article-title":"Protective action of amlodipine on cardiac negative inotropism induced by lipopolysaccharide in rats","volume":"100","author":"Bravo","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1254\/jjp.89.157","article-title":"Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide\/interferon-\u03b3-stimulated cultured vascular smooth muscle cells","volume":"89","author":"Chou","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2010.05.003_bib61","first-page":"67","article-title":"Adjunct antimicrobial therapy\u2014prospects for the future","volume":"2","author":"Barrett","year":"2005","journal-title":"Therapy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T10:50:32Z","timestamp":1635591032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0924857910002037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.05.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}